Support for down-tuning of the calreticulin gene in the process of human evolution

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 7, 2011, Pages 1770-1773

  Esmaeilzadeh Gharehdaghi, E ^a   Banan, M ^a   Farashi, S ^a   Mirabzadeh, A ^a   Farokhashtiani, T ^a   Hosseinkhani, S ^b   Heidari, A ^a   Najmabadi, H ^a   Ohadi, M ^a  

^a UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Calreticulin; Cognition; Mutation; Promoter; Psychosis

Indexed keywords

CALRETICULIN; NUCLEOTIDE;

ADULT; ALLELE; ARTICLE; CALR GENE; CANCER CELL CULTURE; CELL STRAIN HEK293; COGNITIVE DEFECT; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENETIC CONSERVATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MUTATIONAL ANALYSIS; NONHUMAN; PROMOTER REGION; SEQUENCE HOMOLOGY;

ADULT; BIOLOGICAL EVOLUTION; CALRETICULIN; COGNITION DISORDERS; HEK293 CELLS; HUMANS; MALE; MUTATION; NEUROBLASTOMA; PROMOTER REGIONS, GENETIC; SCHIZOPHRENIA, PARANOID; SEQUENCE HOMOLOGY; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 79961126786     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.06.009     Document Type: Article

References (23)

1. Aghajani A., Rahimi A., Fadai F., Ebrahimi A., Najmabadi H., Ohadi M. A point mutation at the calreticulin gene core promoter conserved sequence in a case of schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2006, 141B:294-295.
2. Altara C.A., Hunta R.A., Jurataa L.W., Websterb M.J., Derbya E., Gallaghera P., Lemirea A., Brockmana J., Laenga P. Insulin, IGF-1, and muscarinic agonists modulate schizophrenia-associated genes in human neuroblastoma cells. Biol Psychiatry 2008, 64:1077-1087.
3. Arion D., Unger T., Lewis D.A., Levitt P., Mirnics K. Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry 2007, 62:711-721.
4. Bodmer W., Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 2008, 40:695-701.
5. Caligiuri M.P., Hellige J.B., Cherry B.J., Kwok W., Lulow L.L., Lohr J.B. Lateralized cognitive dysfunction and psychotic symptoms in schizophrenia. Schizophr Res 2005, 80:151-161.
6. De Lima A.D., Gieseler A., Voigt T. Relationship between GABAergic interneurons migration and early neocortical network activity. Dev Neurobiol 2009, 69:105-123.
7. Deslauriers J., Lefrançois M., Larouche A., Sarret P., Grignon S. Antipsychotic-induced DRD2 upregulation and its prevention by α-lipoic acid in SH-SY5Y neuroblastoma cells. Synapse 2011, 65:321-331.
8. Farokhashtiani T., Mirabzadeh A., Olad Nabi M., Ghaem Magham Z., Khorram Khorshid H.R., Najmabadi H., et al. Reversion of the human calreticulin gene promoter to the ancestral type as a result of a novel psychosis-associated mutation. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:541-544.
9. Higashino A., Kageyama T. Development-dependent expression of calreticulin in the brain and other tissues of the Japanese monkey, Macaca fuscata. J Med Primatol 2008, 37:303-310.
10. Jaskolski F., Normand E., Mulle C., Coussen F. Differential trafficking of GluR7 kianate receptor subunit splice variants. J Biol Chem 2005, 280:22968-22976.
11. Kyosseva S.V. Differential expression of mitogen-activated protein kinases and immediate early genes fos and jun in thalamus in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:997-1006.
12. Lee J.G., Cho H.Y., Park S.W., Seo M.K., Kim Y.H. Effects of olanzapine on brain-derived neurotrophic factor gene promoter activity in SH-SY5Y neuroblastoma cells. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:1001-1006.
13. Michalak M., Corbett E.F., Mesaeli N., Nakamura K., Opas M. Calreticulin: one protein, one gene, many functions. Biochem J 1999, 344:281-292.
14. Mohrluder J., et al. Identification of calreticulin as a ligand of GABARAP by phage display screening of a peptide library. FEBS J 2007, 274:5543-5555.
15. Nakamura M., Sato K., Fukaya M., Araishi K., Aiba A., Kano M., et al. Signaling complex formation of phospholipase Cα4 with metabotropic glutamate receptor type 1α and 1, 4, 5-trisphosphate receptor at the perisynapse and endoplasmic reticulum in the mouse brain. Eur J Neurol 2004, 20:2929-2944.
16. Nunes A., Ohadi M., Rahimi A., Aghajani A., Najmabadi H., Curraisa A., et al. A mutation in the calreticulin gene promoter in a family case of schizoaffective disorder leads to its aberrant transcriptional activation. Brain Res 2008, 1239:36-41.
17. Olad Nabi M., Mirabzadeh A., Feizzadeh G., Khorshid H.R., Karimlou M., Yeganeh M.Z., et al. Novel mutations in the calreticulin gene core promoter and coding sequence in schizoaffective disorder. Am J Med Genet B Neuropsychiatr Genet 2010, 153B:347-349.
18. Olkku A., Mahonen A. Calreticulin mediated glucocorticoid receptor export is involved in beta-catenin translocation and Wnt signalling inhibition in human osteoblastic cells. Bone 2009, 44:555-565.
19. Prabhakar S., Visel A., Akiyama J.A., Shoukry M., Lewis K.D., Holt A., et al. Human-specific gain of function in a developmental enhancer. Science 2008, 321:1346-1350.
20. Tabuchi A. Synaptic plasticity-regulated gene expression: a key event in the long-lasting changes of neuronal function. Biol Pharm Bull 2008, 31:327-335.
21. Villa A., Liste I., Courtois E.T., Seiz E.G., Ramos M., Meyer M., et al. Generation and properties of a new human ventral mesencephalic neural stem cell line. Exp Cell Res 2009, 315:1860-1874.
22. Wada T., Penninger J.M. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 2004, 23:2838-2849.
23. Yamazaki T., Muramoto M., Nishimura S., Kita Y. Suppressive effects of FR167653, an inhibitor of p38 mitogen-activated kinase, on calreticulin mRNA expression induced by endoplasmicreticulum stresses. Eur J Pharmacol 2004, 484:147-156.